For help on how to get the results you want, see our search tips.
5 results
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Summaries of opinion Remove Summaries of opinion filter
Medicine type
Conditional approval Remove Conditional approval filter
Biosimilar Remove Biosimilar filter
Additional monitoring Remove Additional monitoring filter
Exceptional circumstances Remove Exceptional circumstances filter
Categories
Human Remove Human filter
Application type
Initial authorisation Remove Initial authorisation filter
-
List item
Summary of opinion: Zynlonta
loncastuximab tesirine, opinion date: 15/09/2022, Positive, Last updated: 19/09/2022 -
List item
Summary of opinion: Vegzelma
bevacizumab, opinion date: 23/06/2022, Positive, Last updated: 21/06/2022 -
List item
Summary of opinion: Ebvallo
tabelecleucel, opinion date: 13/10/2022, Positive, Last updated: 14/10/2022 -
List item
Summary of opinion: Livmarli
Maralixibat chloride, opinion date: 13/10/2022, Positive, Last updated: 14/10/2022 -
List item
Summary of opinion: Kauliv (new)
teriparatide, opinion date: 10/11/2022, Positive, Last updated: 11/11/2022